Show simple item record

dc.contributor.authorHarrington, KJ
dc.contributor.authorBhide, SA
dc.contributor.authorForster, MD
dc.contributor.authorGood, JS
dc.contributor.authorGunn, L
dc.contributor.authorKong, A
dc.contributor.authorMelcher, AA
dc.contributor.authorMetcalf, R
dc.contributor.authorNenclares, P
dc.contributor.authorNewbold, KL
dc.contributor.authorNutting, CM
dc.contributor.authorPrestwich, R
dc.contributor.authorSacco, JJ
dc.contributor.authorSoliman, H
dc.contributor.authorWong, KH
dc.date.accessioned2020-06-22T09:57:36Z
dc.date.issued2020-08
dc.identifier.citationClinical oncology (Royal College of Radiologists (Great Britain)), 2020, 32 (8), pp. 490 - 492
dc.identifier.issn0936-6555
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3759
dc.identifier.eissn1433-2981
dc.identifier.doi10.1016/j.clon.2020.05.016
dc.formatPrint-Electronic
dc.format.extent490 - 492
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://www.rioxx.net/licenses/under-embargo-all-rights-reserved
dc.titleLooking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer.
dc.typeOther
rioxxterms.versionofrecord10.1016/j.clon.2020.05.016
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/under-embargo-all-rights-reserved
rioxxterms.licenseref.startdate2020-08
rioxxterms.typeOther
dc.relation.isPartOfClinical oncology (Royal College of Radiologists (Great Britain))
pubs.issue8
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Immunotherapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Immunotherapy/Translational Immunotherapy (TL)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR/Students
pubs.organisational-group/ICR/Students/PhD and MPhil
pubs.organisational-group/ICR/Students/PhD and MPhil/20/21 Starting Cohort
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Immunotherapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Immunotherapy/Translational Immunotherapy (TL)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR/Students
pubs.organisational-group/ICR/Students/PhD and MPhil
pubs.organisational-group/ICR/Students/PhD and MPhil/20/21 Starting Cohort
pubs.publication-statusPublished
pubs.volume32
pubs.embargo.termsNo embargo
icr.researchteamTargeted Therapyen_US
icr.researchteamTranslational Immunotherapyen_US
dc.contributor.icrauthorNenclares, Pabloen
dc.contributor.icrauthorHarrington, Kevinen
dc.contributor.icrauthorMelcher, Alanen


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record